US · Healthcare

C21 Investments Inc (CXXIF)

Drug Manufacturers - Specialty & Generic

C21 Investments Inc (CXXIF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for CXXIF

P/E ratio
18.00

C21 Investments Inc (CXXIF) — FAQ

What is CXXIF's P/E ratio?

The price-to-earnings (P/E) ratio for C21 Investments Inc (CXXIF) is 18.00 (data as of 2026-03-24).

Does C21 Investments Inc pay a dividend?

Dividend yield is not available in the current snapshot for C21 Investments Inc (CXXIF). Check the MyAverix Finance app for the latest dividend data.

What sector is C21 Investments Inc in?

C21 Investments Inc (CXXIF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is CXXIF listed on?

CXXIF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play